Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 38c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $34.00 -0.79%
EPS Growth %: -27.8%
Financial Fact:
Total Costs and Operating Expenses: 3.84M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -27.8%
Financial Fact:
Total Costs and Operating Expenses: 3.84M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($1.20), $0.38 worse than the analyst estimate of ($0.82).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- RBC Capital Reiterates Sector Perform Rating on Freehold Royalties Ltd. (FRU:CN) (FRHLF)
- InMed Pharmaceuticals gets Nasdaq equity deficiency notice
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
